Dabigatran etexilate
NDC 43598-642, Dabigatran etexilate, capsule, from Dr.Reddys Laboratories Inc.
- Product NDC
- 43598-642
- Status
- Listed
- Labeler
- Dr.Reddys Laboratories Inc
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208048
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43598-642 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DABIGATRAN ETEXILATE MESYLATE75 mg/1
Pharmacologic classes
Direct Thrombin Inhibitor [EPC]; Thrombin Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43598-642-60 | 43598064260 | 60 CAPSULE in 1 BOTTLE (43598-642-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a608e019-db9a-d6fb-cd0d-cecc1351a2b1NADAC price for package 43598064260
GET /v1/drugs/nadac/43598064260
Use it
Look up 43598-642 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43598-642 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43598-642. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.